Atlas Trials

A Study of Oral Insulin to Reduce Liver Fat Content in Type 2 Diabetes Patients With Nonalcoholic Steatohepatitis (NASH)

Clinical trial NCT04616014 · COMPLETED

Trial details

NCT number
NCT04616014
Sponsor
Oramed, Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Nonalcoholic Steatohepatitis (NASH)
Start date
2021-03-01
Primary completion
2022-07-01
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.